Here are relevant reports on : rapid-dna-analysis-market
-
Aptamers Market by Product Type (DNA, RNA, XNA), Technology (SELEX), Application (Therapeutics, Diagnostics, R&D), End Users (Pharmaceutical & Biotechnology Companies, Academic & Government Research Institutes, CROs) - Global Forecast to 2026
The global aptamers market growth is primed to transition from $151 million in 2021 to $342 million by 2026, showcasing a strong CAGR of 17.7%. Growth of the market is attributed to factors such as increase in number of clinical trials for development of aptamer-based therapeutics, increase in awareness about advantages of aptamers as compared to antibodies, rising investment in pharmaceutical R&D, and rising prevalence of chronic and rare diseases to increase the demand for aptamer-based therapeutics and diagnostics. Growth in the venture capital funding for research on aptamers and growing collaborations with research institutes and pharmaceutical companies are also expected to offer a wide range of growth opportunities to players in the market.
- Published: November 2021
- Price: $ 4950
- TOC Available:
-
North America Epigenetics Market by Product & Service [Enzymes, Kits & Reagents (Antibodies), Software], Method [DNA Methylation, Histone Modification], Technique [NGS, PCR], Application [Oncology, Immunology, Developmental Biology]-Forecast to 2030
The North America epigenetics market, valued at USD 0.84 billion in 2024, stood at USD 0.93 billion in 2025 and is projected to advance at a resilient CAGR of 13.8% from 2025 to 2030, culminating in a forecasted valuation of USD 1.78 billion by the end of the period. Growth of the North America epigenetics market is driven by a strong, well-funded life sciences ecosystem, with rising oncology and precision-medicine programs that rely on methylation and chromatin profiling.
- Published: January 2026
- Price: $ 4950
- TOC Available:
-
Apoptosis Assays Market by Product (Caspase, Annexin V, DNA Fragmentation, Mitochondrial Assay), Detection Technology (Flow Cytometry, Florescence microscopy), Application (Stem Cell, Discovery & Development, Clinical Research) & Region - Global Forecasts to 2023
The global apoptosis assays market is projected to reach USD 5.9 billion by 2023, at a CAGR of 10.5%. The prominent players in the apoptosis assays market are Merck KGaA (Germany), Thermo Fisher Scientific (US), Bio-Rad Laboratories (US), Becton, Dickinson and Company (US), GE Healthcare (US), Sartorius AG (Germany), Danaher Corporation (US), Geno Technology (US), GeneCopoeia, Inc. (US), Bio-Techne Corporation(US), BioTek Instruments (US), PerkinElmer (US), Promega Corporation (US), Biotium (US), Abcam plc (UK), Canvax (Spain), Abnova (Taiwan), and Creative Bioarray (US).
- Published: November 2018
- Price: $ 4950
- TOC Available:
-
Molecular Weight Marker Market by Products (DNA, RNA, Protein Ladders), Type (Prestained, Specialty), Application (PCR, Western Blotting, Gel Extraction), & End User (Academic Institutes, Pharmaceutical Companies, CRO) - Global Forecast to 2019
The global molecular weight marker market was valued at $265.36 million in 2014 and is poised to grow at a CAGR of 12.23 % between 2014 and 2019, to reach $472.47 million in 2019. Increased research and development spending by biotechnology and pharmaceutical companies, increasing public funding for life science research, and new innovations in genomics and proteomics research will drive the growth of the molecular weight markers market.
- Published: February 2015
- Price: $ 4950
- TOC Available:
-
NGS Sample Preparation Market by Product (Reagents & Consumables, Workstations), Workflow (Library Prep, Target Enrichment), Sample Type (DNA), Application (Diagnostics, Drug Discovery), Method (Microfluidic, Automated), End User & Region - Global Forecast to 2028
The global NGS sample preparation market in terms of revenue was estimated to be worth $1.9 billion in 2022 and is poised to reach $4.0 billion by 2028, growing at a CAGR of 13.4% from 2022 to 2028. The market for NGS sample preparation is highly consolidated, with key players strategizing to capture the market. Prominent players in the NGS sample preparation market are Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), PerkinElmer Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Agilent Technologies, Inc. (US), Danaher (US), Becton, Dickinson and Company (US), Merck KGAA (Germany), QIAGEN (Germany), Bio-Rad Laboratories, Inc. (US), Promega Corporation (US), Eurofins Scientific (Luxembourg), BGI (China), 10x Genomics (US), Sysmex Corporation (US), Psomagen (US), Zymo Research Corporation (US), Takara Bio Inc. (Japan), Novogene Co., Ltd. (China), New England Biolabs (US), Tecan Trading AG (US), Oxford Nanopore Technologies PLC (UK), PacBio (US), Medgenome (US), and Swift Biosciences Inc. (US).
- Published: March 2023
- Price: $ 4950
- TOC Available:
-
Carrier Screening Market by Product and Service, Type (Expanded (Customized, Predesigned) Targeted Diseases, Medical condition (Hematologic, Pulmonary), Technology (DNA Sequencing, PCR), End User, Region - Global Forecast to 2028
The global carrier screening market, valued at US$1.8 billion in 2022, stood at US$2.2 billion in 2023 and is projected to advance at a resilient CAGR of 19.7% from 2023 to 2028, culminating in a forecasted valuation of US$5.4 billion by the end of the period. The expansion of this market is majorly due to the development and availability of expanded carrier screening panels that cover a wide range of genetic conditions contribute to the market's growth.
- Published: January 2024
- Price: $ 4950
- TOC Available:
-
Molecular Quality Controls Market Product (Independent Control, Instrument Specific Control (PCR, DNA Sequencing), Application (Infectious Disease Diagnostics), Analyte type, End User (Hospitals, Diagnostic Lab), Region- Global Forecast to 2028
The global molecular quality controls market, valued at US$0.2 billion in 2022, stood at US$0.2 billion in 2023 and is projected to advance at a resilient CAGR of 6.6% from 2023 to 2028, culminating in a forecasted valuation of US$0.3 billion by the end of the period. The growth of this market is primarily driven by the increasing number of accredited clinical laboratories, growing adoption of third-party quality controls, and increasing government funding for genomic projects.
- Published: July 2023
- Price: $ 4950
- TOC Available:
-
COVID-19 Impact on Food Safety Testing Market by Testing Technologies (DNA-based, Immunoassay-based, Chromatography- & Spectroscopy-based), Targets Tested (Pathogen, GMO, Allergen, and Mycotoxin), and Region - Global Forecast to 2021
The COVID-19 impact on food safety testing market is expected to grow from USD 10.5 billion in 2020 to USD 13.3 billion by 2021 at a compound annual growth rate (CAGR) of 21.4% during the forecast period.The key players in this market include Eurofins (Luxembourg), SGS (Switzerland), Intertek (UK), Bureau Veritas (France), and TUV SUD (Germany). Eurofins (Luxembourg) is an international group of laboratories that provide testing and support services to the food industries as well as to governments.
- Published: April 2020
- Price: $ 4950
- TOC Available:
-
DNA Diagnostics Market by Product (Instruments, Reagents & Kits, Services & Software), Technology (PCR, Mass Spectroscopy, Microarrays), Application (Infectious Disease (Hepatitis, HIV, HPV), Oncology), Specimen (Blood, Urine) - Global Forecast to 2029
The global DNA diagnostics market, valued at US$12.3 billion in 2023, stood at US$13.3 billion in 2024 and is projected to advance at a resilient CAGR of 9.7% from 2024 to 2029, culminating in a forecasted valuation of US$21.2 billion by the end of the period. Growth in the market is primarily driven by the technological improvements in the DNA diagnostics industry and the growing need for personalized treatment and early disease diagnosis in developing nations. Also, the increased investments by healthcare-based companies are majorly contributing to growth of the market.
- Published: July 2024
- Price: $ 4950
- TOC Available:
-
Asia Pacific Epigenetics Market by Offering [Enzymes, Kits & Reagents, Software, Services], Method [DNA Methylation, Histone Modification], Technique [NGS, PCR], Application [Oncology, Immunology, Developmental Biology], End User - Forecast to 2030
The Asia Pacific epigenetics market, valued at US$0.44 billion in 2024, stood at US$0.49 billion in 2025 and is projected to advance at a resilient CAGR of 14.6% from 2025 to 2030, culminating in a forecasted valuation of US$0.97 billion by the end of the period. The Asia Pacific epigenetics market is experiencing growth, driven by increasing demand for precise biomarker discovery and multi-omics research across oncology, immunology, and precision medicine programs.
- Published: March 2026
- Price: $ 4950
- TOC Available:
Records 21 to 30 of 50
